NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Compliance Implementation Services
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CIS Wins Prestigious Business Award by the Philadelphia 100 - Compliance Implementation Services (CIS), a consulting firm specializing in compliance strategies for pharmaceutical companies, announced that the organization was recognized as one of the fastest growing private companies in the Philadelphia
CIS Wins Prestigious Business Award by the Philadelphia 100

 

NewswireToday - /newswire/ - Philadelphia, PA, United States, 2009/09/23 - Compliance Implementation Services (CIS), a consulting firm specializing in compliance strategies for pharmaceutical companies, announced that the organization was recognized as one of the fastest growing private companies in the Philadelphia.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Compliance Implementation Services (CIS), announced that the organization was recently recognized as one of the fastest growing private companies in the Philadelphia 100.

“Out of the 700 nominated companies, we are very proud and honored to be recognized as one of the fastest 100 growing companies in the Philadelphia region,” said Jim Collins, CIS VP Operations and Co-Founder. “For the past five years, CIS has made a concerted effort to continually build out our service offerings and provide smart, effective solutions to our pharmaceutical clients faced with regulatory compliance concerns.”

“This award is a reflection of the dedication and commitment by CIS employees who help differentiate us among other industry consultants based on their quality work deliverables and exceeding client expectations,” said Toni Barsh, CIS VP Account Management and Co-Founder. “We have established a unique position in the marketplace that offers both strategic and tactical consultation and an unselfish desire to assist our clients with their compliance strategies and needs. I take great pride in our accomplishments, am energized each day that I work with my partner Jim and respect the direction our Senior Management Team has provided.”

Philadelphia 100® is a joint project of the Wharton Small Business Development Center, the Entrepreneurs’ Forum of Greater Philadelphia and the Philadelphia Business Journal.

About Compliance Implementation Services (CIS)
CIS (cis-partners.com) is a consulting firm specializing in compliance strategies for pharmaceutical companies, from Global Clinical Research & Development through U.S. Commercial Compliance and Government Programs. Founded in 2004, our deep understanding of industry laws and regulations, innovative and practical applications and custom solutions help our clients establish a “Culture of Compliance” that is both meaningful and practical.

Our experts quickly identify your exposure to compliance risks, help you develop a strategic plan, and ensure its implementation and ongoing adherence to legal and regulatory requirements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Compliance Implementation Services

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CIS Wins Prestigious Business Award by the Philadelphia 100

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Jackie O'Connor - CIS-Partners.com 
484-445-7200 jacquelineoconnor[.]cis-partners.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Compliance Implementation Services securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Compliance Implementation Services / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments
PharmaEssentia Selects Veeva Data Cloud to Support Launch of Novel Therapy for Rare, Chronic Blood Cancers
Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050 - A Novel Individualized Neoantigen Cancer Vaccine
DSM Plans New Production Site for Bovaer® in Dalry, Scotland
Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit SkyRFID, LLC

Visit  JobsWare.com





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)